Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890841793> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2890841793 endingPage "392" @default.
- W2890841793 startingPage "387" @default.
- W2890841793 abstract "Breast cancer is the major cause of death from cancer among women around the world. Given the drug resistance in the treatment of this disease, it is very important to identify new therapies and anticancer drugs. Many studies demonstrated that hypericin could induce apoptosis in different cancer cell lines; however, the underlying mechanism is not well understood yet. Therefore, this study aimed to evaluate the anticancer effect of hypericin in two breast cancer cell lines, one with wild type P53 and the other with mutant P53.In this study, the MDA-MB-231 and MDA-MB-175-VII cell lines were treated with different concentrations of hypericin for 24 and 48 hours. The measurement of cell death was performed by MTT assay. The cell apoptosis rate was measured using annexin V/propidium iodide assay through flow cytometry. The level of expression in P21 and P53 genes was evaluated by real time PCR. Immunocytochemistry (ICC) analysis was performed for P21 (direct target for P53 protein) to confirm the results.The results showed that hypericin could have dose-dependent cytotoxic effects on the MDA-MB-231 and MDA-MB-175-VII cell lines, and its cytotoxicity is much higher in the latter cells. According to flow cytometry results, 86% of MDA-MB-175-VII cells underwent apoptosis with IC50 dose of hypericin for MDA-MB-231 cells after 24 hours. Moreover, after 24 hours of exposure to hypericin with MDA- MB-231 IC50 concentration, the expression of P53 and P21 genes upregulated in MDA-MB-175-VII much more than MDA-MB-231 when both cell lines were treated with 24 hours IC50 dose of MDA-MB-231. The ICC analysis on P21 confirmed that by treating both cell lines with MDA-MB-231 IC50 dose of hypericin for 24 hours, this protein is overexpressed much more in MDA-MB-175-VII cells.The results of this study demonstrated that hypericin's apoptotic and cytotoxic effects on cancer cells may be mediated via P53 overexpression, cell cycle arrest and the subsequent apoptosis. Therefore, it is of great importance to consider that hypericin would have better impact on cells or tumors with wild type P53." @default.
- W2890841793 created "2018-09-27" @default.
- W2890841793 creator A5003064750 @default.
- W2890841793 creator A5009120250 @default.
- W2890841793 creator A5024676005 @default.
- W2890841793 creator A5034244579 @default.
- W2890841793 creator A5035229807 @default.
- W2890841793 creator A5052899771 @default.
- W2890841793 creator A5057991471 @default.
- W2890841793 creator A5087644721 @default.
- W2890841793 date "2018-09-01" @default.
- W2890841793 modified "2023-09-26" @default.
- W2890841793 title "Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231." @default.
- W2890841793 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30221528" @default.
- W2890841793 hasPublicationYear "2018" @default.
- W2890841793 type Work @default.
- W2890841793 sameAs 2890841793 @default.
- W2890841793 citedByCount "2" @default.
- W2890841793 countsByYear W28908417932020 @default.
- W2890841793 crossrefType "journal-article" @default.
- W2890841793 hasAuthorship W2890841793A5003064750 @default.
- W2890841793 hasAuthorship W2890841793A5009120250 @default.
- W2890841793 hasAuthorship W2890841793A5024676005 @default.
- W2890841793 hasAuthorship W2890841793A5034244579 @default.
- W2890841793 hasAuthorship W2890841793A5035229807 @default.
- W2890841793 hasAuthorship W2890841793A5052899771 @default.
- W2890841793 hasAuthorship W2890841793A5057991471 @default.
- W2890841793 hasAuthorship W2890841793A5087644721 @default.
- W2890841793 hasConcept C121608353 @default.
- W2890841793 hasConcept C1491633281 @default.
- W2890841793 hasConcept C153911025 @default.
- W2890841793 hasConcept C154317977 @default.
- W2890841793 hasConcept C185592680 @default.
- W2890841793 hasConcept C190283241 @default.
- W2890841793 hasConcept C202751555 @default.
- W2890841793 hasConcept C2775934118 @default.
- W2890841793 hasConcept C2778432610 @default.
- W2890841793 hasConcept C2780783641 @default.
- W2890841793 hasConcept C31573885 @default.
- W2890841793 hasConcept C502942594 @default.
- W2890841793 hasConcept C54355233 @default.
- W2890841793 hasConcept C553184892 @default.
- W2890841793 hasConcept C55493867 @default.
- W2890841793 hasConcept C81885089 @default.
- W2890841793 hasConcept C86803240 @default.
- W2890841793 hasConcept C88634738 @default.
- W2890841793 hasConcept C96232424 @default.
- W2890841793 hasConcept C98274493 @default.
- W2890841793 hasConceptScore W2890841793C121608353 @default.
- W2890841793 hasConceptScore W2890841793C1491633281 @default.
- W2890841793 hasConceptScore W2890841793C153911025 @default.
- W2890841793 hasConceptScore W2890841793C154317977 @default.
- W2890841793 hasConceptScore W2890841793C185592680 @default.
- W2890841793 hasConceptScore W2890841793C190283241 @default.
- W2890841793 hasConceptScore W2890841793C202751555 @default.
- W2890841793 hasConceptScore W2890841793C2775934118 @default.
- W2890841793 hasConceptScore W2890841793C2778432610 @default.
- W2890841793 hasConceptScore W2890841793C2780783641 @default.
- W2890841793 hasConceptScore W2890841793C31573885 @default.
- W2890841793 hasConceptScore W2890841793C502942594 @default.
- W2890841793 hasConceptScore W2890841793C54355233 @default.
- W2890841793 hasConceptScore W2890841793C553184892 @default.
- W2890841793 hasConceptScore W2890841793C55493867 @default.
- W2890841793 hasConceptScore W2890841793C81885089 @default.
- W2890841793 hasConceptScore W2890841793C86803240 @default.
- W2890841793 hasConceptScore W2890841793C88634738 @default.
- W2890841793 hasConceptScore W2890841793C96232424 @default.
- W2890841793 hasConceptScore W2890841793C98274493 @default.
- W2890841793 hasIssue "9" @default.
- W2890841793 hasLocation W28908417931 @default.
- W2890841793 hasOpenAccess W2890841793 @default.
- W2890841793 hasPrimaryLocation W28908417931 @default.
- W2890841793 hasRelatedWork W1906256219 @default.
- W2890841793 hasRelatedWork W2070449743 @default.
- W2890841793 hasRelatedWork W2153162223 @default.
- W2890841793 hasRelatedWork W2348629719 @default.
- W2890841793 hasRelatedWork W2355064692 @default.
- W2890841793 hasRelatedWork W2359363401 @default.
- W2890841793 hasRelatedWork W2367461549 @default.
- W2890841793 hasRelatedWork W2414051820 @default.
- W2890841793 hasRelatedWork W2789717442 @default.
- W2890841793 hasRelatedWork W56025907 @default.
- W2890841793 hasVolume "21" @default.
- W2890841793 isParatext "false" @default.
- W2890841793 isRetracted "false" @default.
- W2890841793 magId "2890841793" @default.
- W2890841793 workType "article" @default.